Melanoma in 2015: Immune-checkpoint blockade - durable cancer control

Nat Rev Clin Oncol. 2016 Feb;13(2):77-8. doi: 10.1038/nrclinonc.2015.237. Epub 2016 Jan 20.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • CTLA-4 Antigen / immunology
  • Clinical Trials, Phase III as Topic
  • Genes, cdc / drug effects
  • Genes, cdc / immunology
  • Humans
  • Immunotherapy / methods*
  • Immunotherapy / trends
  • Ipilimumab
  • Melanoma / immunology
  • Melanoma / pathology
  • Melanoma / therapy*
  • Neoplasm Metastasis
  • Nivolumab
  • Programmed Cell Death 1 Receptor / immunology

Substances

  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Ipilimumab
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Nivolumab